202 related articles for article (PubMed ID: 12468217)
1. Controlled release of an osteogenic peptide from injectable biodegradable polymeric composites.
Hedberg EL; Tang A; Crowther RS; Carney DH; Mikos AG
J Control Release; 2002 Dec; 84(3):137-50. PubMed ID: 12468217
[TBL] [Abstract][Full Text] [Related]
2. Controlled drug release from a novel injectable biodegradable microsphere/scaffold composite based on poly(propylene fumarate).
Kempen DH; Lu L; Kim C; Zhu X; Dhert WJ; Currier BL; Yaszemski MJ
J Biomed Mater Res A; 2006 Apr; 77(1):103-11. PubMed ID: 16392139
[TBL] [Abstract][Full Text] [Related]
3. In vitro degradation of porous poly(propylene fumarate)/poly(DL-lactic-co-glycolic acid) composite scaffolds.
Hedberg EL; Shih CK; Lemoine JJ; Timmer MD; Liebschner MA; Jansen JA; Mikos AG
Biomaterials; 2005 Jun; 26(16):3215-25. PubMed ID: 15603816
[TBL] [Abstract][Full Text] [Related]
4. Effect of varied release kinetics of the osteogenic thrombin peptide TP508 from biodegradable, polymeric scaffolds on bone formation in vivo.
Hedberg EL; Kroese-Deutman HC; Shih CK; Crowther RS; Carney DH; Mikos AG; Jansen JA
J Biomed Mater Res A; 2005 Mar; 72(4):343-53. PubMed ID: 15666357
[TBL] [Abstract][Full Text] [Related]
5. Local injection of thrombin-related peptide (TP508) in PPF/PLGA microparticles-enhanced bone formation during distraction osteogenesis.
Wang Y; Wan C; Szöke G; Ryaby JT; Li G
J Orthop Res; 2008 Apr; 26(4):539-46. PubMed ID: 17960653
[TBL] [Abstract][Full Text] [Related]
6. TGF-beta1 release from biodegradable polymer microparticles: its effects on marrow stromal osteoblast function.
Lu L; Yaszemski MJ; Mikos AG
J Bone Joint Surg Am; 2001; 83-A Suppl 1(Pt 2):S82-91. PubMed ID: 11314800
[TBL] [Abstract][Full Text] [Related]
7. Effect of different sustained bone morphogenetic protein-2 release kinetics on bone formation in poly(propylene fumarate) scaffolds.
Olthof MGL; Kempen DHR; Herrick JL; Yaszemski MJ; Dhert WJA; Lu L
J Biomed Mater Res B Appl Biomater; 2018 Feb; 106(2):477-487. PubMed ID: 28186684
[TBL] [Abstract][Full Text] [Related]
8. Development of biodegradable poly(propylene fumarate)/poly(lactic-co-glycolic acid) blend microspheres. II. Controlled drug release and microsphere degradation.
Kempen DH; Lu L; Zhu X; Kim C; Jabbari E; Dhert WJ; Currier BL; Yaszemski MJ
J Biomed Mater Res A; 2004 Aug; 70(2):293-302. PubMed ID: 15227674
[TBL] [Abstract][Full Text] [Related]
9. Injectable biodegradable polymer composites based on poly(propylene fumarate) crosslinked with poly(ethylene glycol)-dimethacrylate.
He S; Yaszemski MJ; Yasko AW; Engel PS; Mikos AG
Biomaterials; 2000 Dec; 21(23):2389-94. PubMed ID: 11055286
[TBL] [Abstract][Full Text] [Related]
10. Degradable, antibiotic releasing poly(propylene fumarate)-based constructs for craniofacial space maintenance applications.
Henslee AM; Shah SR; Wong ME; Mikos AG; Kasper FK
J Biomed Mater Res A; 2015 Apr; 103(4):1485-97. PubMed ID: 25046733
[TBL] [Abstract][Full Text] [Related]
11. Crosslinking characteristics of an injectable poly(propylene fumarate)/beta-tricalcium phosphate paste and mechanical properties of the crosslinked composite for use as a biodegradable bone cement.
Peter SJ; Kim P; Yasko AW; Yaszemski MJ; Mikos AG
J Biomed Mater Res; 1999 Mar; 44(3):314-21. PubMed ID: 10397934
[TBL] [Abstract][Full Text] [Related]
12. In vitro degradation of polymeric networks of poly(propylene fumarate) and the crosslinking macromer poly(propylene fumarate)-diacrylate.
Timmer MD; Ambrose CG; Mikos AG
Biomaterials; 2003 Feb; 24(4):571-7. PubMed ID: 12437951
[TBL] [Abstract][Full Text] [Related]
13. In vivo degradation of porous poly(propylene fumarate)/poly(DL-lactic-co-glycolic acid) composite scaffolds.
Hedberg EL; Kroese-Deutman HC; Shih CK; Crowther RS; Carney DH; Mikos AG; Jansen JA
Biomaterials; 2005 Aug; 26(22):4616-23. PubMed ID: 15722131
[TBL] [Abstract][Full Text] [Related]
14. Development of an injectable, in situ crosslinkable, degradable polymeric carrier for osteogenic cell populations. Part 3. Proliferation and differentiation of encapsulated marrow stromal osteoblasts cultured on crosslinking poly(propylene fumarate).
Payne RG; McGonigle JS; Yaszemski MJ; Yasko AW; Mikos AG
Biomaterials; 2002 Nov; 23(22):4381-7. PubMed ID: 12219828
[TBL] [Abstract][Full Text] [Related]
15. Controlled release of hyaluronan oligomers from biodegradable polymeric microparticle carriers.
Hedberg EL; Shih CK; Solchaga LA; Caplan AI; Mikos AG
J Control Release; 2004 Nov; 100(2):257-66. PubMed ID: 15544873
[TBL] [Abstract][Full Text] [Related]
16. Effect of autologous bone marrow stromal cell seeding and bone morphogenetic protein-2 delivery on ectopic bone formation in a microsphere/poly(propylene fumarate) composite.
Kempen DH; Kruyt MC; Lu L; Wilson CE; Florschutz AV; Creemers LB; Yaszemski MJ; Dhert WJ
Tissue Eng Part A; 2009 Mar; 15(3):587-94. PubMed ID: 18925831
[TBL] [Abstract][Full Text] [Related]
17. In vitro release of transforming growth factor-beta 1 from gelatin microparticles encapsulated in biodegradable, injectable oligo(poly(ethylene glycol) fumarate) hydrogels.
Holland TA; Tabata Y; Mikos AG
J Control Release; 2003 Sep; 91(3):299-313. PubMed ID: 12932709
[TBL] [Abstract][Full Text] [Related]
18. Development of an injectable, in situ crosslinkable, degradable polymeric carrier for osteogenic cell populations. Part 2. Viability of encapsulated marrow stromal osteoblasts cultured on crosslinking poly(propylene fumarate).
Payne RG; McGonigle JS; Yaszemski MJ; Yasko AW; Mikos AG
Biomaterials; 2002 Nov; 23(22):4373-80. PubMed ID: 12219827
[TBL] [Abstract][Full Text] [Related]
19. Augmentation of osteoinduction with a biodegradable poly(propylene glycol-co-fumaric acid) bone graft extender. A histologic and histomorphometric study in rats.
Lewandrowski KU; Bondre S; Gresser JD; Silva AE; Wise DL; Trantolo DJ
Biomed Mater Eng; 1999; 9(5-6):325-34. PubMed ID: 10822488
[TBL] [Abstract][Full Text] [Related]
20. Controlled release of rhBMP-2 loaded poly(dl-lactic-co-glycolic acid)/calcium phosphate cement composites in vivo.
Ruhé PQ; Boerman OC; Russel FG; Spauwen PH; Mikos AG; Jansen JA
J Control Release; 2005 Aug; 106(1-2):162-71. PubMed ID: 15972241
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
